GlaxoSmithKline Pharma names Vishwanath Swarup as Commercial Head - General Medicines Ruchika Sharma9 July 2025 5:32 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Vishwanath Swarup as Commercial Head - General Medicines....
SEC Asks Abbott to Submit More Data on Vitamin C Plus D3 FDC Chewable Tablet, Cites Lack of Justification Dr. Divya Colin14 Jun 2025 6:19 PM ISTNew Delhi: In response to the proposal presented by Abbott, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
FDA Approves Abbott's Tendyne TMVR System for Mitral Valve Disease Dr. Prem Aggarwal30 May 2025 8:30 AM ISTThe US Food and Drug Administration has approved Abbott's Tendyne Transcatheter Mitral Valve Replacement (TMVR) system. It is indicated for patients...
USFDA approves Abbott Tendyne to replace mitral valve without open-heart surgery Ruchika Sharma29 May 2025 3:15 PM ISTAbbott Park: Abbott has announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve...
CDSCO Panel Clears Abbott's Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More Sites Dr. Divya Colin26 May 2025 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Abbott Healthcare...
Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac Farhat Nasim9 May 2025 7:51 PM ISTEmpagliflozin plain and its combination with Linagliptin currently account for about 80% of total sales in this Rs 745 crore market.
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
Abbott begins new Intravascular Lithotripsy trial to improve outcomes in Coronary Artery Disease patients Ruchika Sharma25 March 2025 2:30 PM ISTAbbott Park: Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA Farhat Nasim24 Feb 2025 5:12 PM ISTVonoprazan-based GI drugs led new launches, generating Rs 187 crore from 404 brands.
Indian Pharma Market Sees 8.7% Growth in January 2025, But Vaccines, Ophthalmology Struggle Farhat Nasim10 Feb 2025 6:47 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) recorded an 8.7% year-on-year (YoY) growth in January 2025, reaching a monthly value of Rs 19,238...
Cipla elevates Achin Gupta as new Global Chief Operating Officer Ruchika Sharma29 Jan 2025 1:16 PM ISTMumbai: Cipla has announced the appointment of Achin Gupta, Chief Executive Officer - One India Business (SMP) as the Global Chief Operating Officer...
Indian Pharma Market Reached Rs 2,21,425 Crore in 2024: PharmaTrac Farhat Nasim8 Jan 2025 3:59 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) witnessed significant progress in December 2024, registering a 7.7% growth in value and a 1.1%...
